Article Versions Notes

Li F, Peng J, Feng H, Yang Y, Gao J, Liu C, Xu J, Zhao Y, Pan S, Wang Y, et al. KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARγ/NRF2 Signalling. Cells. 2022; 11(21):3393. https://doi.org/10.3390/cells11213393

Li, Fangfang, Jingfeng Peng, Hui Feng, Yiming Yang, Jianbo Gao, Chunrui Liu, Jie Xu, Yanru Zhao, Siyu Pan, Yixiao Wang, and et al. 2022. "KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARγ/NRF2 Signalling" Cells 11, no. 21: 3393. https://doi.org/10.3390/cells11213393

Li, F., Peng, J., Feng, H., Yang, Y., Gao, J., Liu, C., Xu, J., Zhao, Y., Pan, S., Wang, Y., Xu, L., Qian, W., & Zong, J. (2022). KLF9 Aggravates Streptozotocin-Induced Diabetic Cardiomyopathy by Inhibiting PPARγ/NRF2 Signalling. Cells, 11(21), 3393. https://doi.org/10.3390/cells11213393